Ramkumar V, Olah M E, Jacobson K A, Stiles G L
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
Mol Pharmacol. 1991 Nov;40(5):639-47.
Desensitization of adenosine receptors (ARs) was studied in DDT1 MF-2 cells, which possess both A1- and A2AR, differentially coupled to adenylate cyclase. (-)-N6-(R)-Phenylisopropyladenosine (R-PIA), an A1AR-selective agonist at the appropriate concentrations, desensitized A1AR-mediated inhibition of adenylate cyclase activity in a time- (t1/2, 8 hr) and dose-dependent and reversible fashion. This was associated with significant decreases in total A1AR number and in the number of receptors possessing a high affinity for agonist in membrane preparations. The decrease in total A1AR in the membranes from the desensitized cells (approximately 40%) was associated with a 37% increase in A1AR measured in light vesicle preparations, compared with control cells. To test a possible role of phosphorylation in A1AR desensitization, cells were incubated with [32P]orthophosphate, followed by exposure to R-PIA for 18 hr. Subsequent purification of the A1AR indicated a 3-4-fold increase in phosphorylation of A1AR in cells treated with R-PIA, compared with control cells. Desensitization of the A1AR did not alter the levels of alpha s and alpha 12 proteins or affect the ability of stimulatory effectors, such as isoproterenol, sodium fluoride, and forskolin, to activate adenylate cyclase. These results suggest that uncoupling, down-regulation, and phosphorylation of the A1AR contribute, at least in part, to desensitization of this inhibitory receptor. Desensitization of the A2AR was characterized using an A2-selective agonist, 2-[4-(2-(4-aminophenyl]methylcarbonyl)ethyl)phenyl]ethylamino- 5'-N-ethylcarboxamidoadenosine (PAPA-APEC). Pretreatment of cells with PAPA-APEC (100 nM) resulted in a rapid loss of agonist stimulation of adenylate cyclase activity (t1/2 of this effect, 45 min). This effect was dose dependent (EC50, approximately 10 nM) and rapidly reversible. Interestingly, desensitization of the A2AR resulted in no change in receptor number, affinity, or mobility on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Taken together, these data suggest distinct mechanisms of desensitization of A1- and A2ARs in a single cell type.
在同时拥有A1和A2腺苷受体(AR)且与腺苷酸环化酶呈不同偶联关系的DDT1 MF - 2细胞中研究了AR的脱敏作用。( - ) - N6 - (R) - 苯基异丙基腺苷(R - PIA),在适当浓度下是A1AR选择性激动剂,它能使A1AR介导的腺苷酸环化酶活性抑制以时间(t1/2,8小时)、剂量依赖性且可逆的方式脱敏。这与膜制剂中A1AR总数以及对激动剂具有高亲和力的受体数量显著减少有关。与对照细胞相比,脱敏细胞的膜中A1AR总数减少(约40%),而轻囊泡制剂中测得的A1AR增加了37%。为了测试磷酸化在A1AR脱敏中的可能作用,将细胞与[32P]正磷酸盐一起孵育,然后用R - PIA处理18小时。随后对A1AR进行纯化表明,与对照细胞相比,用R - PIA处理的细胞中A1AR的磷酸化增加了3 - 4倍。A1AR的脱敏并未改变αs和α12蛋白的水平,也不影响诸如异丙肾上腺素、氟化钠和福斯可林等刺激性效应物激活腺苷酸环化酶的能力。这些结果表明,A1AR的解偶联、下调和磷酸化至少部分地促成了这种抑制性受体的脱敏。使用A2选择性激动剂2 - [4 - (2 - (4 - 氨基苯基)甲基羰基)乙基]苯基]乙氨基 - 5'- N - 乙基羧酰胺腺苷(PAPA - APEC)对A2AR的脱敏进行了表征。用PAPA - APEC(100 nM)预处理细胞导致腺苷酸环化酶活性的激动剂刺激迅速丧失(此效应的t1/2为45分钟)。这种效应是剂量依赖性的(EC50,约10 nM)且迅速可逆。有趣的是,A2AR的脱敏导致受体数量、亲和力或在十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳上的迁移率没有变化。综上所述,这些数据表明在单一细胞类型中A1和A2AR的脱敏机制不同。